Sermorelin vs Ipamorelin vs CJC-1295: Practical Differences
Sermorelin, ipamorelin, and CJC-1295 get lumped together, but they work through different mechanisms and suit different patients. Here is how the two growth hormone pathways work, why the peptides get combined, and which protocol fits which goal.
The FDA Peptide Crackdown: What Patients Need to Know in 2026
The FDA did not simply ban peptides. It placed several in a restricted category, removed some in 2026, and scheduled a review for late July 2026 to decide what can be compounded. Here is the framework, the timeline, and what it means for patients.
GLP-1 Muscle Loss: A Clinical Framework to Prevent It
Rapid weight loss on semaglutide or tirzepatide costs muscle if you do not plan for it. The trial data confirms the loss is real and largely preventable. Here is the protein, training, dose, and supplement framework that actually works.
Peptide Therapy Explained: A Physician’s Guide to BPC-157, CJC-1295, and Beyond
Peptides are one of the most talked about treatments in health optimization. Learn what they actually do, which ones matter, and whether they might help you.
